Results 81 to 90 of about 662,207 (147)

SGLT2 inhibitor ameliorates hypertension by regulating the CYP4A/20-HETE pathway in the kidney. [PDF]

Biosci Rep
Zhou Z, Hang W, Zhao R, Jiang J, Wu J, Wang DW.   +5 more
europepmc   +1 more source

Sex-consistent outcomes in SGLT2 inhibitor-treated acute myocardial infarction patients: a real-world study

Background Sex-related differences in outcomes of sodium-glucose co-transporter 2 (SGLT2) inhibitors therapy in acute myocardial infarction remain inconclusive. Methods This real-world retrospective study compared sex disparities in primary outcomes (pro-
Rui-Yun Wu, Chen Guo, Shan Zhao, Jia-Hao Dou, Fan-Shun Guo, Su Liu, Yi-Wei Hu, Jin Wei   +7 more
core   +1 more source

Prurigo pigmentosa in patient with diabetes on SGLT2 inhibitor. [PDF]

JAAD Case Rep
Khan T, Hirsch Y, McGivney R, Hoyer S.
europepmc   +1 more source

Bibliometric analysis of SGLT2 inhibitor treatment for diabetic kidney disease. [PDF]

Ren Fail
Hu D, Chen L, Mai R, Gao T, Guan B.
europepmc   +1 more source

SGLT2 inhibitor prescription at discharge in very old adults with heart failure irrespective of diabetes status. [PDF]

Int J Cardiol Heart Vasc
Esser R, Harboun M, Larbaneix M, Mondragon A, Balesdent S, Esteban M, Corny J, Farges C, Palermo V, Pages N, Nisse Durgeat S, Maurou O.   +11 more
europepmc   +1 more source

A Systematic Review and Expert Evaluation of Perioperative SGLT2 Inhibitor-Associated Ketoacidosis Case Reports. [PDF]

Acta Anaesthesiol Scand
Snel LIP, Li X, Jamaludin F, Siegelaar SE, Holleman F, Vriesendorp TM, DeVries JH, Hoekstra JBL, Preckel B, van Raalte DH, Hermanides J, Hulst AH.   +11 more
europepmc   +1 more source

Distinct metabolomic signatures of SGLT2 inhibitor vs. sulfonylurea in a paired human liver biopsy study. [PDF]

Biochem Biophys Rep
Takeshita Y, Oo HK, Nakano Y, Ueno A, Oishi M, Tsujiguchi H, Soga T, Yamashita T, Honda M, Takamura T.   +9 more
europepmc   +1 more source

SGLT2 Inhibitor Use in Type 2 Diabetes in England: A Population-Based Cross-Sectional Study of Uptake of NICE Guidance. [PDF]

Diabetes Obes Metab
Muller P, Wray J, Rahman M, Hawkins J, Bakhai C, Cuthbertson DJ, Willans R, Yelland E, Rowark S, Watras M, Sheridan Rains L, Adler AI, Owen L.   +12 more
europepmc   +1 more source

Preoperative SGLT2 Inhibitor Use and Outcomes After Major Cardiac Procedures: A Propensity Score-Matched Analysis of the TriNetX Network. [PDF]

J Clin Med
Khawar MMH, Ahmed F, Elnashar M, Lewis CV, Shahid M, Shuja AA, Afzal F, Sajjad N, Khan MA, Atta M, Arshad U, Khawar M, Dalir N, Tahir HB.   +13 more
europepmc   +1 more source

Early safety observations of peri-transplant SGLT2 inhibitor use in lung transplant recipients. [PDF]

J Thorac Dis
Kaniuk JK, Miyashita Y, Reichenbach R, Perez S, Kaiho T, Yagi Y, Nagano T, Arunachalam A, Kurihara C.   +8 more
europepmc   +1 more source